Abstract

The status of serotonin 5­HT2A receptors (5­HT2ARs) in schizophrenia has been controversial. In vivo positron emission tomography neuroimaging and in vitro post-mortem binding studies have reported conflicting results about 5­HT2AR density. Radiotracers bind different receptor conformations depending on their agonist, antagonist or inverse agonist properties. This study investigates 5­HT2AR density in the post-mortem prefrontal cortex from subjects with schizophrenia and controls using three radiotracers with a different pharmacological profile. The specific binding parameters of the inverse agonist [18F]altanserin, the agonist [3H]lysergic acid diethylamide (LSD) and the antagonist [3H]MDL100907 to brain cortex membranes from 20 subjects with schizophrenia and 20 individually matched controls were evaluated under similar methodological conditions. Ten schizophrenia subjects were antipsychotic-free at death. Saturation curve analyses were performed by non-linear regression to obtain a maximal density of binding sites (Bmax) and the affinity of the respective radiotracers (Kd). In schizophrenia subjects, 5-HT2AR density was decreased when quantified by [18F]altanserin binding, whereas increased when evaluated by [3H]LSD binding. However, [3H]MDL100907 binding was unaltered. A slight loss of affinity (higher Kd) was observed exclusively in [3H]LSD binding. The findings were more evident in antipsychotic-free subjects than in antipsychotic-treated subjects. In conclusion, a higher proportion of the 5-HT2AR-active functional conformation, which is rather identified by agonist radiotracers, was observed in schizophrenia patients. A consequent reduction of the inactive 5-HT2AR conformation, which is preferentially identified by inverse agonist radiotracers, was also obtained. Antagonist radiotracers do not distinguish between molecular conformations of the receptor, and accordingly, the absence of changes was shown. These results are compatible with the proposed increased functional activity of brain cortical 5-HT2ARs in schizophrenia.

Details

Title
Opposite alterations of 5­HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile
Author
Diez-Alarcia Rebeca 1   VIAFID ORCID Logo  ; Muguruza Carolina 1   VIAFID ORCID Logo  ; Rivero Guadalupe 1   VIAFID ORCID Logo  ; García-Bea Aintzane 2 ; Gómez-Vallejo, Vanessa 3 ; Callado, Luis F 1   VIAFID ORCID Logo  ; Llop Jordi 4 ; Abraham, Martín 5 ; Javier, Meana J 1   VIAFID ORCID Logo 

 University of the Basque Country, Department of Pharmacology, Leioa, Spain (GRID:grid.11480.3c) (ISNI:0000000121671098); Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Bizkaia, Spain (GRID:grid.469673.9) (ISNI:0000 0004 5901 7501); Biocruces Bizkaia Health Research Institute, Barakaldo, Spain (GRID:grid.469673.9) 
 University of the Basque Country, Department of Pharmacology, Leioa, Spain (GRID:grid.11480.3c) (ISNI:0000000121671098); Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Bizkaia, Spain (GRID:grid.469673.9) (ISNI:0000 0004 5901 7501) 
 CIC BiomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia/San Sebastian, Spain (GRID:grid.424269.f) (ISNI:0000 0004 1808 1283) 
 CIC BiomaGUNE, Basque Research and Technology Alliance (BRTA), Donostia/San Sebastian, Spain (GRID:grid.424269.f) (ISNI:0000 0004 1808 1283); Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
 Achucarro Basque Center for Neuroscience, Leioa, Spain (GRID:grid.427629.c); IKERBASQUE Basque Foundation for Science, Bilbao, Spain (GRID:grid.424810.b) (ISNI:0000 0004 0467 2314) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2529598735
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.